| scholarly article | Q13442814 |
| P50 | author | Michael Parks | Q38361090 |
| P2093 | author name string | Fiona MacDonald | |
| Trevor Cole | |||
| Denise Williams | |||
| Julie Hewitt | |||
| Mike Griffiths | |||
| Samantha Court | |||
| Siobhan Cleary | |||
| Stephanie Allen | |||
| Samuel Clokie | |||
| Benjamin Bowns | |||
| P2860 | cites work | Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 |
| Non-invasive prenatal testing: a review of international implementation and challenges | Q26999426 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| A Non-Invasive Droplet Digital PCR (ddPCR) Assay to Detect Paternal CFTR Mutations in the Cell-Free Fetal DNA (cffDNA) of Three Pregnancies at Risk of Cystic Fibrosis via Compound Heterozygosity | Q28550894 | ||
| Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield | Q28744238 | ||
| Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma | Q33682367 | ||
| Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women | Q33917070 | ||
| Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis | Q34028063 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Best practice guidelines for molecular analysis in spinal muscular atrophy | Q34314037 | ||
| Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing | Q34433169 | ||
| High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma | Q34618332 | ||
| Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. | Q36311237 | ||
| Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. | Q36354562 | ||
| Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage | Q36895493 | ||
| Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples | Q37004989 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Non-invasive prenatal diagnosis and determination of fetal Rh status | Q37077064 | ||
| The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made | Q38099617 | ||
| Non-invasive prenatal diagnosis: progress and potential | Q38208530 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. | Q40057027 | ||
| New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. | Q40078199 | ||
| Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. | Q41475376 | ||
| Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing | Q44339091 | ||
| Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. | Q45026733 | ||
| Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies | Q50146668 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom | Q57839586 | ||
| Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia | Q74446351 | ||
| New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations | Q80833713 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Non-invasive prenatal diagnosis of single-gene disorders from maternal blood | Q84073855 | ||
| Technical standards and guidelines for spinal muscular atrophy testing | Q84362191 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | spinal muscular atrophy | Q580290 |
| muscular atrophy | Q2844600 | ||
| P304 | page(s) | 416-422 | |
| P577 | publication date | 2017-01-25 | |
| P1433 | published in | European Journal of Human Genetics | Q2155433 |
| P1476 | title | Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage | |
| P478 | volume | 25 |
| Q90297790 | Development and validation of a haplotype-free technique for non-invasive prenatal diagnosis of spinal muscular atrophy |
| Q98475414 | Evaluation of Beta -Thalassemia in the Fetus through cffDNA with Multiple Polymorphisms as a Haplotype in the Beta-Globin Gene |
| Q90467894 | Fast Temperature-Gradient COLD PCR for the enrichment of the paternally inherited SNPs in cell free fetal DNA; an application to non-invasive prenatal diagnosis of β-thalassaemia |
| Q47423413 | Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population |
| Q50051267 | Non-invasive prenatal testing for fetal inheritance of maternal β-thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study |
| Q89556540 | Noninvasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA |
| Q90366836 | Noninvasive prenatal diagnosis of β-thalassemia by relative haplotype dosage without analyzing proband |
| Q47900162 | Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping |
| Q89501954 | The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study |
| Q47191639 | cfDNA screening and diagnosis of monogenic disorders - where are we heading? |
Search more.